Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled carbon monoxide for prevention of delayed graft function after deceased-donor kidney transplantation
ISRCTN42763074Phase 2Recruiting
- Sponsor
- Proterris
- Start
- Apr 2024
- Modality
- Small Molecules
01
Overview
Phase 2, randomised trial in delayed graft function (DGF) and kidney allograft rejection comparing Inhaled carbon monoxide with Placebo (medical air) (2 arms). Primary endpoints: Incidence of adverse events and Rate of delayed graft function. Started Apr 2024; status: recruiting.
02
Drugs
Carbon monoxide
03
Conditions
delayed graft function (DGF)kidney allograft rejection
Beyond the preview
Go deeper on ISRCTN42763074.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN42763074.